The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.
RT’s Three Key Takeaways:
- Research Partnership Renewal: Monash University and Brigham and Women’s Hospital have extended their collaboration to advance clinical trials and preventive treatments in sleep and circadian medicine.
- Focus on Chronic Disease: The research initiative investigates how sleep and circadian rhythms influence conditions such as obstructive sleep apnea, cardiovascular disease, and mental health.
- Wearable Technology Integration: The partnership prioritizes the use of biotechnology and wearable devices to improve healthcare access and identify early risks for chronic diseases.
Monash University and Brigham and Women’s Hospital (BWH) announced the renewal of a research partnership during a ceremony in Boston to advance innovation in sleep and circadian medicine.
The collaboration between the Australian university and the Boston-based hospital, a teaching affiliate of Harvard Medical School, will focus on investigating the intersection of sleep, physical activity, nutrition, mental health, and chronic disease. Researchers aim to conduct multi-center clinical trials to deliver new preventive medicine and treatments.
A key component of the research involves the use of biotechnology, including wearable devices, to improve accessible healthcare for patients at risk of chronic disease.
“Monash University’s Turner Institute for Brain and Mental Health has the potential to open new possibilities for health and wellbeing improvements across the lifespan,” said Emmanuel Stamatakis, director of the Monash Brain Park at the Turner Institute for Brain and Mental Health.
Stamatakis said that sleep and circadian science represent underrecognized frontiers for medical innovation that require integration with established areas like nutrition and physical activity. He noted that recent research into small bursts of daily movement suggests a role in preventing type 2 diabetes, highlighting the value of digital healthcare solutions.
The partnership has contributed to more than 250 publications since it began in 2009. This research includes work on light biology, shift work safety, and obstructive sleep apnea, as well as links to cardiovascular disease, dementia, and personalized treatment approaches.
“The partnership between Monash University and Brigham and Women’s Hospital is imperative to advancing research on sleep and circadian rhythm at a global scale,” said Shantha Rajaratnam, head of the Monash School of Psychological Sciences, in a news release.
Rajaratnam leads the partnership alongside Dr Charles Czeisler from BWH and Harvard Medical School. The collaboration is supported by the Monash Boston Hub in Kendall Square, which connects biotechnology and pharmaceutical partners with the university’s research ecosystem.
“By combining Monash’s strengths in translational research and clinical trials with the scientific and clinical leadership of Brigham and Women’s Hospital and Harvard Medical School, we are creating new opportunities to accelerate discovery and improve patient outcomes,” said Robyn Ward, deputy vice-chancellor (research and enterprise) at Monash University, in a news release.
